The rapid spread and uncontrollable evolution of antibiotic-resistant bacteria have already
become urgent global to treat bacterial infections. Sonodynamic therapy (SDT), a …

Many active ingredients currently prescribed show limited therapeutic efficacy, mainly due to
their dissolution rate inadequate to treat the pathology of interest. A large drug particle size …

Abstract Ibrutinib (PCI-32765), marketed under the trade name IMBRUVICA, is a first-in-
class irreversible inhibitor drug of Bruton tyrosine kinase (BTK). In the current research, its …

The biofilms produced by the aggregation of bacterial colonies are among the major
obstacles of host immune system monitoring and antimicrobial treatment. Herein, we report …

An efficient bio-conditioning of the nanomaterial for microbial inhibition and catalytic
degradation has been recognized as a promising solution to protect public health and …

Solubility of capecitabine (CPT) in a ternary system (supercritical carbon dioxide (sc-CO2)+
CPT+[methanol, ethanol, and dimethyl sulfoxide (DMSO)] as cosolvents) was measured at …

Poor bioavailability and aqueous solubility represent a major constraint during the
development of new API molecules and can influence the impact of new medicines or halt …

The use of nanotechnology has revolutionized many biotechnological sectors, from
bioengineering to medicine, passing through food and cosmetic fields. However, their clinic …

Despite the success, it is highly challenging to battle against pathogenic biofilms-based
chronic bacterial infections by conventional antibiotic therapy. Herein, we report a near …

In recent years, the stimuli-responsive delivery of drugs based on diselenide-bridged
polymeric nanocomposites have gathered significant attention from researchers towards …